1. Home
  2. REE vs LEXX Comparison

REE vs LEXX Comparison

Compare REE & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REE
  • LEXX
  • Stock Information
  • Founded
  • REE 2011
  • LEXX 2004
  • Country
  • REE Israel
  • LEXX Canada
  • Employees
  • REE N/A
  • LEXX N/A
  • Industry
  • REE Auto Manufacturing
  • LEXX Biotechnology: Pharmaceutical Preparations
  • Sector
  • REE Consumer Discretionary
  • LEXX Health Care
  • Exchange
  • REE Nasdaq
  • LEXX Nasdaq
  • Market Cap
  • REE 22.4M
  • LEXX 22.7M
  • IPO Year
  • REE N/A
  • LEXX N/A
  • Fundamental
  • Price
  • REE $0.86
  • LEXX $1.09
  • Analyst Decision
  • REE Strong Buy
  • LEXX Strong Buy
  • Analyst Count
  • REE 2
  • LEXX 1
  • Target Price
  • REE $11.75
  • LEXX $4.00
  • AVG Volume (30 Days)
  • REE 1.1M
  • LEXX 283.7K
  • Earning Date
  • REE 12-16-2025
  • LEXX 11-25-2025
  • Dividend Yield
  • REE N/A
  • LEXX N/A
  • EPS Growth
  • REE N/A
  • LEXX N/A
  • EPS
  • REE N/A
  • LEXX N/A
  • Revenue
  • REE $183,000.00
  • LEXX $615,923.00
  • Revenue This Year
  • REE $327.73
  • LEXX $46.98
  • Revenue Next Year
  • REE $36,888.82
  • LEXX $17.26
  • P/E Ratio
  • REE N/A
  • LEXX N/A
  • Revenue Growth
  • REE N/A
  • LEXX 49.85
  • 52 Week Low
  • REE $0.53
  • LEXX $0.77
  • 52 Week High
  • REE $11.72
  • LEXX $2.85
  • Technical
  • Relative Strength Index (RSI)
  • REE 39.10
  • LEXX 57.73
  • Support Level
  • REE $1.06
  • LEXX $0.99
  • Resistance Level
  • REE $1.10
  • LEXX $1.21
  • Average True Range (ATR)
  • REE 0.12
  • LEXX 0.08
  • MACD
  • REE -0.05
  • LEXX 0.02
  • Stochastic Oscillator
  • REE 0.03
  • LEXX 61.41

About REE REE Automotive Ltd.

REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is in early stages of commercialization and develop and produce software-defined vehicle (SDV) technology that manages vehicle operations and features through proprietarily-developed software. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

Share on Social Networks: